Gastric emptying in patients with autoimmune pancreatitis

Pancreas. 2011 Nov;40(8):1302-6. doi: 10.1097/MPA.0b013e3182204541.

Abstract

Objectives: Autoimmune pancreatitis (AIP) and its extrapancreatic lesions seem to be clinical manifestations of organs involved in IgG4-related systemic disease. To clarify whether the stomach is a target organ, gastric function was evaluated in patients with AIP.

Methods: In 6 patients with AIP, gastric emptying was assessed by Carbon 13 (¹³C) acetate breath test before and after steroid therapy. Based on 4-hour breath samples, the half ¹³CO₂ excretion time (T(1/2)) and the time of maximal excretion (T(max)) were calculated as gastric emptying parameters. Data of 20 healthy volunteers were used as controls. The number of IgG4-positive plasma cells in gastrofiberscopic biopsy specimens was counted before and after steroid therapy.

Results: Both T(1/2) and T(max) in patients with AIP decreased significantly after steroid therapy (T(1/2): 1.89 ± 0.21 hours vs 1.69 ± 0.15 hours, P = 0.046; and T(max): 1.1 ± 0.2 hours vs 0.96 ± 0.2 hours, P = 0.027), and became similar to those of the controls (T(1/2): 1.69 ± 0.32 hours and T(max): 0.98 ± 0.2 hour). The number of IgG4-positive plasma cells infiltrating the gastric mucosa decreased after steroid therapy.

Conclusions: Gastric emptying was impaired in patients with AIP and improved to the reference range after steroid therapy. The stomach may be a target organ of IgG4-related systemic disease.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / physiopathology
  • Breath Tests / methods
  • Carbon Isotopes
  • Drug Administration Schedule
  • Female
  • Gastric Emptying / drug effects*
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / immunology
  • Gastric Mucosa / microbiology
  • Gastroscopy
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use
  • Helicobacter Infections / microbiology
  • Helicobacter Infections / physiopathology
  • Helicobacter pylori / isolation & purification
  • Humans
  • Immunoglobulin G / immunology
  • Male
  • Middle Aged
  • Pancreatitis / drug therapy*
  • Pancreatitis / physiopathology
  • Plasma Cells / drug effects
  • Plasma Cells / immunology
  • Prednisolone / administration & dosage
  • Prednisolone / therapeutic use*
  • Prospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Carbon Isotopes
  • Glucocorticoids
  • Immunoglobulin G
  • Prednisolone